✦ LIBER ✦

CV12 A COST-EFFECTIVENESS ANALYSIS OF ACE INHIBITOR TRANDOLAPRIL AS A PREVENTATIVE TREATMENT OF HEART-FAILURE PROGRESSION

✍ Scribed by H Lilliu; C Le Pen; K Lamiraud; W Wittenberg

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CV3 A COST-EFFECTIVENESS ANALYSIS OF CAN

✍ M Lamotte; L Annemans; B Schockaert 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB

PCD11: THE COST-EFFECTIVENESS ANALYSIS A

✍ SG Gorokhova; PA Vorobiev 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

CV4 CANTWO A'S RESULT IN A FAILURE?: EFF

✍ DH Shah; NM Parikh; PS Kamble; H Chen; M Johnson 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB

PUK8 COST-EFFECTIVENESS OF SCREENING FOR

✍ J Atthobari; C Boersma; R Gansevoort; PE De Jong; LT De Jong-van den Berg; MJ Po 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB

PCV47 DECISION ANALYSIS ON EFFECTIVENESS

✍ A Goehler; R Dietz; KJ Osterziel; U Siebert 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

Use of valsartan for the treatment of he

✍ Dean G. Smith; Annamaria Cerulli; Feride H. Frech 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 690 KB